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Abstract
Background: Common variants rs6232 and rs6235 in the PCSK1 gene have been associated with obesity in European
populations. We aimed to evaluate the contribution of these variants to obesity and related traits in Mexican children and
adults.
Methodology/Principal Findings: Rs6232 and rs6235 were genotyped in 2382 individuals, 1206 children and 1176 adults.
Minor allele frequencies were 0.78% for rs6232 and 19.99% for rs6235. Rs6232 was significantly associated with childhood
obesity and adult class III obesity (OR=3.01 95%CI 1.64–5.53; P=4 610
24 in the combined analysis). In addition, this SNP
was significantly associated with lower fasting glucose levels (P=0.01) and with increased insulin levels and HOMA-B
(P=0.05 and 0.01, respectively) only in non-obese children. In contrast, rs6235 showed no significant association with
obesity or with glucose homeostasis parameters in any group.
Conclusion/Significance: Although rs6232 is rare in the Mexican population, it should be considered as an important risk
factor for extreme forms of obesity.
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Introduction
The prevalence of obesity has increased worldwide, including
Mexico, where more than 70% of the adults and 26% of the
children are overweight or obese [1]. Even though obesity has a
strong genetic contribution, the identification of genes related to
obesity risk has proven difficult [2–4]. The discovery of genes
causing monogenic forms of obesity such as the prohormone
convertase subtilisin/kexin type 1 gene (PCSK1) has greatly
improved our understanding of the pathophysiology of obesity
[2–4]. This gene encodes an enzyme expressed in neuroendo-
crine cells that converts inactive prohormones into functional
key hormones that regulate central and/or peripheral energy
metabolism. Although loss-of-function mutations in this gene
causing childhood obesity and impaired glucose tolerance are
rare [5–7], two common nonsynonymous variants (rs6232 and
rs6235) were recently found to be strongly associated with
childhood and adulthood obesity in European population [8].
Functional in vitro analysis of these variants revealed a significant
impairment of the catalytic activity of the enzyme for rs6232
(N221D), but no enzyme activity alteration for rs6235 (S690T)
[8].
Several studies have sought to replicate the association of
these variants (mainly rs6235) with obesity and obesity-
associated traits in Asian and European adult populations, with
inconsistent results [9–15]. These population-based studies
included only a reduced number of obese class III individuals
and did not include children as the initial report of Benzinou et
al. [8]. This may partially explain such inconsistencies, as
genetic influences on BMI may be stronger precisely in children
and individuals with class III obesity [2,16]. Thus, the aim of
the present study was to analyze the association of rs6232 and
rs6235 with obesity and related traits in a case-control analysis
of Mexican-Mestizo adults and children.
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Subjects
The study included 1206 non-related Mexican-Mestizo children
aged 5 to 12 years (596 boys and 610 girls), recruited at a summer
camp for children of employees of the Mexican Health Ministry
(Convivencia Infantil 2008–2009, Secretarı ´a de Salud) and the
Hospital Infantil de Me ´xico. Body mass index (BMI) was
calculated as weight in kilograms divided by height in meter
squared. BMI z-scores and percentiles were calculated using age
and sex specific BMI reference data, as recommended by the
Centers for Disease Control and Prevention [17]. The population
was stratified based on percentile BMI, 802 children were non-
obese (BMI percentile,95
th) and 404 were obese (BMI percenti-
le$95
th).
The study also included 1176 unrelated Mexican Mestizos aged
18–82 years (806 nonpregnant women and 370 men): 788
individuals described by Villalobos-Compara ´n et al. [18] and
388 additional subjects recruited from Obesity Clinics at the
INCMNSZ and Ruben Len ˜ero Hospital. Two hundred and fifty
four (21.59%) of these individuals had been diagnosed with type 2
diabetes (T2D) according to WHO (World Health Organization)
criteria [19]. Individuals were grouped according to BMI: 562
were non-obese (BMI ,30 kg/m
2), 380 had class I/II obesity
(30# BMI ,40 kg/m
2), and 234 had class III obesity (BMI
$40 kg/m
2). Biochemical parameters were measured in blood
samples obtained after 12-h fast as previously described [20].
Homeostasis model assessment of beta-cell function (HOMA-B)
and insulin sensitivity (HOMA-S) as measures of beta-cell function
and insulin sensitivity were estimated using a computer model
[21]. The characteristics of the children and adult populations are
shown in Table 1.
As part of the eligibility criteria, subjects with thyroid gland
disease or showing weight instability three months prior to the
study were excluded, as well as elderly subjects with signs of
dementia by Mini-Mental state examination [22]. Only individ-
uals born in Mexico whose parents and grandparents identified
themselves as Mexican Mestizos were included. This project was
approved by the Institutional Committee of Biomedical Research
in Humans of the INCMNSZ. All adult participants and parents
of the children provided written informed consent prior to their
inclusion in the study.
Single Nucleotide Polymorphism Genotyping
Rs6232 and rs6235 were genotyped using TaqMan assays (ABI
Prism 7900HT Sequence Detection System; Applied Biosystems,
Foster City, CA). Genotyping call rate exceeded 97% per SNP and
no discordant genotypes were observed in 25 duplicate samples. In
addition, because the Mexican-Mestizo population is admixed, we
analyzed 10 ancestry informative markers to rule out population
stratification [18]. Genotyping was performed by KBiosciences
(Hertfordshire, UK, http://www.kbioscience.co.uk/) using a
KASPar assay system. Genotyping call rates of each ancestry
informative marker exceeded 95%, and no discordant genotypes
were observed in 54 duplicate samples. Deviation from Hardy–
Weinberg equilibrium was not observed for rs6232 and rs6235 in
any group (P.0.66 and P.0.21, respectively).
Statistical Analysis
Logistic regression was used to test for associations between the
rs6232 and rs6235 SNPs and obesity. Children and adult
combined odds ratios were estimated using the Mantel-Haenszel
method. The AdmixMap program was used to test the possible
effect of population stratification on associations of rs6232 with
obesity only in the adult population [23]. Generalized linear
regression was applied to test for associations of rs6232 and rs6235
with quantitative traits only in individuals without T2D. Because
fasting serum insulin levels and HOMA indices were not normally
distributed, they were log transformed for analysis. Interactions
between the SNPs and age or gender were tested by including a
two-way interaction term (SNP*age or SNP*gender) in the model.
All analyses were adjusted for age and gender, and with other
covariates as appropriate. The reported P-values are nominal and
two-sided. Association analyses were performed with SPSS V15.0,
statistical package; Chicago, IL.
Pairwise linkage disequilibrium (LD) between both SNPs was
estimated using Haploview V3.2. (http://www.broad.mit.edu/
mpg/haploview). Power calculations were performed using
QUANTO software (http://hydra.usc.edu/gxe/).
Results
The study included a total of 2382 individuals, 1176 adults and
1206 children. Minor allele frequencies (MAFs) for rs6232 and
rs6235 SNPs were 0.78%, and 19.99%, respectively. Both variants
are in weak linkage disequilibrium (r
2=0.30). Because risk
genotypes frequencies showed no significant differences in lean
and overweight individuals (children or adults; P.0.40), both
groups were considered together as non-obese subjects for the
analyses. SNP rs6232 was significantly associated with obesity in
children (OR=3.78, 95%CI 1.42–9.88; P=7 610
23) and was
significantly associated with class III obesity in adults (OR=2.61,
95%CI 1.10–6.19; P=0.02,) showing a trend of association after
adjusting for admixture (P=0.07). The odds ratio estimated in the
combined analysis was 3.01 (95%CI 1.64–5.53; P=4 610
24,
Table 2). In contrast, the rs6235 variant was not associated with
Table 1. Characteristics of the cases and controls in the
children and adult populations.
Children
Non-obese Obese
N (1206) 802 404
Males (%) 354 (44.13) 236 (58.41)
Age (yrs) 9.4061.92 10.2562.27
z-score BMI 0.3161.00 2.0860.28
Glucose (mmol/L) 5.0060.45 5.0160.52
Insulin (pmol/L) 39.5 (23.6, 59.0) 76.3 (48.6, 108.3)
HOMA-B (%) 76.3 (57.1, 102.7) 125.2 (84.8, 158.7)
HOMA-S (%) 136.5 (90.7, 222.1) 69.1 (49.8, 107.6)
Adults
N (1176) 562 614
Males (%) 191 (33.98) 179 (29.15)
Age (yrs) 47.40614.73 41.91612.68
BMI (Kg/m
2) 24.2062.67 38.5167.65
Glucose (mmol/L) 5.8862.44 6.2062.46
Insulin (pmol/L) 61.1 (39.5, 104.1) 75.0 (45.1, 123.6)
HOMA-B (%) 93.7 (66.3, 131.4) 99.8 (61.2, 136.0)
HOMA-S (%) 83.2 (50.3,130.5) 71.0 (41.2, 116.8)
Data are means 6 s.d. or medians (interquantile range). HOMA-B, homeostasis
model assessment of beta-cell function; HOMA-S, homeostasis model
assessment of insulin sensitivity.
doi:10.1371/journal.pone.0039037.t001
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P=0.20, in the combined analysis, Table 2). No significant
genotype-age or genotype-gender interactions on the risk of
obesity were observed for any SNP (P.0.05 in all tested models).
We also explored the effect of the rs6232 and rs6235 on glucose
homeostasis in non-obese and obese children and in non-diabetic
adults. The rs6232 risk allele was significantly associated with
lower fasting glucose levels (P=0.01) and with increased insulin
levels and HOMA-B (P=0.05 and 0.01, respectively) only in non-
obese children (Table 3). No significant associations between
rs6235 and glucose homeostasis parameters were found in children
or adults (Table 4).
Discussion
Association with Obesity
Obesity is a complex disorder involving both genetic and
environmental factors [2]. Although obesity is highly prevalent in
Mexico, both in children and adults, studies on the genetic
component of this disease in the Mexican population are scarce
[18,20,24]. Recently, N221D (rs6232) and S690T (rs6235) PCSK1
nonsynonymous polymorphisms were found to contribute to the
etiology of polygenic obesity in European populations [8]. In the
present case-control study, the PCSK1 rs6235 was common but not
associated with obesity in Mexican children or adults. This result is
consistent with several recent studies in European and Chinese
populations [9–14]. In contrast, rs6232 was infrequent in the
Mexican population (0.78% as compared to 4–8% in Europeans),
but was significantly associated with obesity in both children and
adults. In fact, the association with obesity for G allele carriers was
significant only in extreme phenotypes (childhood and adult class
III obesity), and was higher than the risk previously reported
(OR=3.01 vs. OR=1.34, respectively) [8]. Thus, it is likely to
provide only a weak population-attributable risk for common
obesity and not to be a major contributor to obesity in the general
population of Mexico. However, the presence of this functional
variant should be considered as a serious risk factor for extreme
forms of obesity in the Mexican population, as has been recently
reported for heterozygous PCSK1 mutations in Europeans [25].
A limitation of the study was low statistical power. For the
combined analysis (children and adults), the present study had only
13.6% and 78.3% statistical power to detect previously reported
associations of rs6232 and rs6235 with obesity, respectively [8].
Because statistical power to detect obesity subclasses was lower, we
cannot rule out the possibility of rs6235 associations with extreme
forms of obesity in this population.
Associations with Glucose Homeostasis
Both rs6235 and rs6232 have been recently associated with
glucometabolic traits. Rs6235 was found to be associated with
decreasing fasting glucose levels and increased HOMA-B [15,26],
while rs6232 was associated with decreased circulating post-
prandial glucose and elevated glucagon levels in a Danish
population-based study [27], and discordantly associated with
decreased fasting insulin levels and reduced insulin sensitivity in
German adults with increased risk of T2D [26]. In the present
study rs6235 was not associated with glucometabolic traits in any
group; however the rs6232 G-allele was significantly associated
with decreased insulin sensitivity only in non-obese children. The
inconsistencies of the effect of PCSK1 variants on glucose
metabolism may result from different study designs and allele
frequencies, particularly in the case of rs6232 which is very
infrequent in the Mexican population. Additional studies are
required to confirm and further characterize the effect of these
polymorphisms on glucose homeostasis.
In conclusion, although the rs6232 polymorphism is rare in the
Mexican population, it is significantly associated with extreme
forms of obesity. However, it is likely not to be a major contributor
to obesity in the general Mexican population. Further studies with
larger samples sizes are needed to confirm this association.
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Table 2. Association of the rs6232 and rs6235 with obesity in children and adult populations.
rs6232 (encoding N221D) rs6235 (encoding S690T)
Children
Genotype (%) Genotype (%)
AA AG GG G allele
frequency
OR (95% CI) P-value GG GC CC C allele
frequency
OR (95% CI) Padd
Non-obese 795 (99.1) 7 (0.9) 0 0.44 528 (66.6) 234 (29.5) 31 (3.9) 18.66
Obese 392 (97.0) 12 (3.0) 0 1.57 3.78 (1.42–9.88) 7610
23 249 (62.9) 132 (33.3) 15 (3.8) 20.45 1.14 (0.92–1.43) 0.21
Adults
Non-obese 550 (97.9) 12 (2.1) 0 1.07 347 (63.9) 172 (31.7) 24 (4.4) 20.26
Obese 595 (96.9) 19 (3.1) 0 1.54 1.35 (0.63–2.91) 0.43 368 (61.5) 209 (34.9) 21 (3.5) 20.73 1.03 (0.83–1.27) 0.74
Class I/II obese 374 (98.4) 6 (1.6) 0 0.79 0.67 (0.24–1.85) 0.44 229 (62.2) 126 (34.2) 13 (3.5) 20.92 1.00 (0.79–1.27) 0.98
Class III obese 221 (94.4) 13 (5.6) 0 2.76 2.61 (1.10–6.19) 0.02 139 (60.4) 83 (36.2) 8 (3.5) 21.52 1.12 (0.84–1.49) 0.43
Combined childhood and adult (class III) analysis
3.01 (1.64–5.53) 4610
24 1.16 (0.96–1.42) 0.20
Data are n (%). All odds ratios and P-values were calculated by logistic regression analyses using non-obese individuals as reference group, adjusting for age, sex and
DT2. Padd, P-values for the additive model.
doi:10.1371/journal.pone.0039037.t002
PCSK1 rs6232 and Extreme Obesity Phenotypes
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39037Author Contributions
Conceived and designed the experiments: MVC SCQ. Performed the
experiments: MVC HVR ELC PLM. Analyzed the data: MVC SRH
TVM SCQ. Contributed reagents/materials/analysis tools: LJA AELF
FJCP BELC TTL BERN CAAS SCQ. Wrote the paper: MVC TVM
SRH CAAS SCQ.
Table 3. Glucose homeostasis parameters in nondiabetic children and adult populations according to PCSK1 rs6232.
Non-obese Obese
Children
AA AG P-value AA AG P-value
N (1206) 795 7 392 12
Age (yrs) 9.4261.92 8.3362.25 0.70 10.2662.29 10.2361.90 0.97
z-score BMI 0.3161.01 0.0561.09 0.60 2.0860.29 2.0860.24 0.98
Glucose (mmol/L) 5.0160.45 4.5960.65 0.01 5.0160.52 4.9660.32 0.72
Insulin (pmol/L) 38.8 (23.6, 59.0) 52.7 (37.8, 59.0) 0.05 76.3 (48.6, 109.0) 70.1 (44.9, 117.8) 0.90
HOMA-B (%) 76.2 (57.1, 102.5) 104.2 (78.1, 122.7) 0.01 125.3 (85.3, 159.3) 118.9 (78.7, 168.2) 0.99
HOMA-S (%) 136.5 (90.5, 222.1) 101.2 (92.8, 167.8) 0.06 69.0 (49.7, 107.3) 76.9 (48.7, 120.5) 0.78
Adults
N (922) 432 10 463 17
Age (yrs) 45.29614.36 41.9622.9 0.46 40.61612.38 36.59615.10 0.20
BMI (kg/m
2) 23.7762.49 23.9262.68 0.56 38.1167.58 41.2067.66 0.18
Glucose (mmol/L) 5.0260.57 4.9960.72 0.88 5.3860.60 5.4960.43 0.39
Insulin (pmol/L) 43.1 (29.9, 61.1) 42.7 (28.3, 49.3) 0.45 105.6 (69.1, 156.9) 136.1 (59.0, 164.3) 0.46
HOMA-B (%) 83.8 (63.9, 108.5) 79.8 (56.5, 98.3) 0.78 130.8 (101.6, 167.7) 132.8 (86.3, 179.0) 0.26
HOMA-S (%) 125.0 (86.2, 177.2) 125.3 (109.6, 190.8) 0.58 50.8 (34.8, 77.3) 38.5 (33.4, 94.9) 0.54
Data are means 6 s.d. or medians (interquantile range). P-values were calculated by generalized linear regression. BMI was adjusted for age and gender. Plasma
glucose/insulin levels and HOMA indices were adjusted for age, gender and BMI. HOMA-B, homeostasis model assessment of beta-cell function; HOMA-S, homeostasis
model assessment of insulin sensitivity.
doi:10.1371/journal.pone.0039037.t003
Table 4. Glucose homeostasis parameters in nondiabetic children and adult populations according to PCSK1 rs6235.
Non-obese Obese
Children
GG GC CC Padd GG GC CC Padd
N (1189) 528 234 31 249 132 15
Age (yrs) 9.4561.90 9.3661.91 8.9661.84 0.20 10.2062.21 10.2862.42 10.4462.02 0.63
z-score BMI 0.3261.01 0.2861.00 0.3560.89 0.88 2.0860.27 2.0960.31 2.0760.22 0.72
Glucose (mmol/L) 5.0460.47 4.9560.40 5.0560.53 0.16 5.0360.51 4.9860.55 5.0460.28 0.71
Insulin (pmol/L) 40.2 (24.3, 59.7) 38.1 (23.6, 59.0) 45.1(21.1, 69.1) 0.77 74.3 (50.8, 106.0) 76.0 (42.5, 118.0) 85.0 (53.8,118.9) 0.17
HOMA-B (%) 76.4 (58.5, 101.0) 77.8 (56.4, 111.1) 73.3 (51.5, 97.6) 0.87 125.6 (87.5, 156.2) 112.3 (81.0, 168.1) 122.7 (101.3, 166.2) 0.16
HOMA-S (%) 135.6 (87.6, 213.2) 138.8 (90.9, 226.6) 116.0 (75.2, 245.9) 0.63 73.0 (51.9, 106.4) 69.3 (44.1, 124.4) 65.60 (45.8, 100.3) 0.34
Adults
N (893) 267 133 22 283 169 19
Age (yrs) 45.7614.7 44.02613.88 45.45617.69 0.40 41.0612.1 39.3613.0 41.0611.5 0.26
BMI (kg/m
2) 23.762.4 23.9262.53 23.8362.55 0.31 38.567.8 37.867.6 38.666.56 0.40
Glucose (mmol/L) 5.762.3 5.5861.91 6.1562.38 0.86 6.062.2 6.162.1 6.362.7 0.59
Insulin (pmol/L) 56.2 (36.9,92.8) 62.5 (40.9, 97.9) 60.7 (42.3, 78.4) 0.23 74.6 (45.8, 132.4) 63.1 (43.05, 111.1) 89.9 (64.7, 130.5) 0.14
HOMA-B (%) 89.7 (67.6, 124.6) 95.7 (70.2, 131.6) 88.2 (58.5, 107.5) 0.79 106.7 (64.4, 141.0) 87.1 (58.0, 127.5) 111.1 (49.3, 161.5) 0.11
HOMA-S (%) 92.0 (53.9, 137.9) 83.8 (51.7, 126.5) 85.3 (66.7, 124.1) 0.24 70.9 (39.7, 116.8) 79.8 (46.6, 123.7) 61.6 (38.4, 77.8) 0.65
Data are means 6 s.d. or medians (interquantile range). Padd-values were calculated by generalized linear regression using an additive model. BMI was adjusted for age
and gender. Plasma glucose/insulin levels and HOMA indices were adjusted for age, gender and BMI. HOMA-B, homeostasis model assessment of beta-cell function;
HOMA-S, homeostasis model assessment of insulin sensitivity.
doi:10.1371/journal.pone.0039037.t004
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